Post-Intensive Care Nutrition Status in Patients with COVID-19

Not Applicable

Completed

• Conditions: COVID- 19; Post-Intensive Care nutrition; Diet and Nutrition - Other diet and nutrition disorders; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12620000602921
• Lead Sponsor: The Australian and New Zealand Intensive Care Research Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-05-25
• Study Completion: 2021-04-30
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 103

Inclusion Criteria

Only patients included in Short Period Incidence Study of Severe Acute Respiratory Infection (SPRINT-SARI) ( https://www.anzics.com.au/current-active-endorsed-research/sprint-sari/) will be included in this nutrition study. Patients admitted to the participating sites and enrolled in SPRINT-SARI will be screened at ICU discharge for eligibility for inclusion in the study. All investigators involved in screening and recruitment are employed by the corresponding sites and will have access to identifiable patient information purely for the purpose of study eligibility and study data collection. The SPRINT-SARI patient identification number (PIN) will be recorded as a case report form data point to allow for data linkage at a later date.
SPRINT-SARI will enrol all patients admitted to hospital with suspected or proven acute novel Coronavirus (nCoV) infection as main cause for admission.

The study population for SPRINT-SARI, as follows:
All patients newly admitted to participating hospitals, of any age, presenting with SARI during the study period. Patients will be eligible for the study if the patient meets the case definition for SARI.

A suspected or proven acute respiratory infection requiring new inpatient admission with onset within the past 14 days. With one or more of the inclusion criteria.
Inclusion Criteria:
-A history of feverishness or measured fever of greater than of equal to 38 deg C;
-Cough;
-Dyspnoea (shortness of breath) OR Tachypnoea.

Additional inclusion for this study:
-COVID-19 positive diagnosis
-Admitted to an Intensive Care Unit (ICU)

Exclusion Criteria

-Admitted to an Intensive Care Unit (ICU) for <24 hours
-Not discharged to an acute ward post an ICU admission
-For palliative care on ICU discharge

Study & Design

• Study Type: Observational
• Study Design: Not specified